These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11596198)

  • 1. [Effect of oxyphenamone, a new inodilator, on isolated cardiac muscles and arteries].
    Fan LL; Sun LH; Lin Y
    Yao Xue Xue Bao; 1997 Nov; 32(11):808-12. PubMed ID: 11596198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of oxyphenamone, a new inodilator, on cardiac hemodynamics in normal rat, cat and dog].
    Fan LL; Sun LH; Li J
    Yao Xue Xue Bao; 1997 Oct; 32(10):744-9. PubMed ID: 11596216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protection of oxyphenamone against cardiac arrest-reperfusion injury of isolated rat hearts].
    Fan LL; Li H; Fan MJ; Zhang RD
    Yao Xue Xue Bao; 2005 Aug; 40(8):705-10. PubMed ID: 16268504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of oxyphenamone on myocardial ischemia in cats and rats].
    Fan LL; Ma J; Wang YF; Ruan YM; Zeng XK
    Yao Xue Xue Bao; 2005 Feb; 40(2):122-6. PubMed ID: 15875666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive inotropic and chronotropic effects of toborinone and its electrophysiological properties in the isolated hearts of rabbits and guinea-pigs.
    Takase H; Orito K; Mori T; Fujiki H; Sekiguchi K; Tominaga M; Iijima T
    Arzneimittelforschung; 1996 Jun; 46(6):579-86. PubMed ID: 8767347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of oxyphenamone on sodium and calcium channels of guinea pig myocardial cells].
    Fan LL; Song Z; Wang TY
    Yao Xue Xue Bao; 2004 Jun; 39(6):410-4. PubMed ID: 15491095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
    Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
    Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protection of oxyphenamone on myocardium against ischemia-reperfusion injury in rat heart].
    Fan LL; Teng J; Zhang RD; Zhao DY
    Yao Xue Xue Bao; 2005 Jun; 40(6):507-12. PubMed ID: 16144314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on vasorelaxations of oxyphenamone and its mechanism].
    Li AL; Ye YX
    Yao Xue Xue Bao; 2002 Jan; 37(1):10-3. PubMed ID: 12579891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212) and its solvent sulfolane on isolated heart preparations of the rat, guinea pig, and dog.
    Grupp G; Grupp IL; Newman G; Schwartz A
    Arzneimittelforschung; 1984; 34(3A):359-63. PubMed ID: 6540089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
    Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
    Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive inotropic effect of the novel forskolin derivative 6-(3-dimethylaminopropionyl)forskolin hydrochloride.
    Hara A; Yokoyama H; Abiko Y
    Arzneimittelforschung; 1995 Dec; 45(12):1257-60. PubMed ID: 8595080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary vasodilation and positive inotropic effect of non steroidal cardiotonics.
    Decker N; Grima M; Schwartz J
    J Pharmacol; 1985; 16(4):391-402. PubMed ID: 4094436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of PGD2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action.
    Hattori Y; Levi R
    J Pharmacol Exp Ther; 1986 Jun; 237(3):719-24. PubMed ID: 3012066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts.
    Zausig YA; Stowe DF; Zink W; Grube C; Martin E; Graf BM
    Anesth Analg; 2006 Jun; 102(6):1646-52. PubMed ID: 16717301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of LAS 31180, a new inotropic/vasodilator quinolone derivative.
    Gras J; Cardelús I; Beleta J; Gristwood RW; Palacios JM; Llenas J
    Arzneimittelforschung; 2000 Nov; 50(11):980-6. PubMed ID: 11148864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new milrinone analog: role of binding to A1 adenosine receptor in its positive inotropic effect on isolated guinea pig and rat atria.
    Floreani M; Borea PA; Gessi S; Mosti L; Fossa P; Dorigo P
    J Pharmacol Exp Ther; 1997 Nov; 283(2):541-7. PubMed ID: 9353368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 7-ethoxycarbonyl-4-hydroxymethyl-6,8-dimethyl-1(2H)-phthalazinone (EG 626), a new phosphodiesterase inhibitor, on the cardiovascular system of the dog.
    Furuta Y; Takahira T; Ueno M
    Arzneimittelforschung; 1985; 35(5):827-32. PubMed ID: 4026906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.